[Pharmacologic justification for the use of adrenergic beta receptor blockaders in angina].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy*; D002395:Catecholamines / Q000037:antagonists & inhibitors; D003326:Coronary Circulation / Q000187:drug effects; D003331:Coronary Vessels / Q000187:drug effects*; D003864:Depression, Chemical; D006801:Humans; D009206:Myocardium / Q000378:metabolism*; D010101:Oxygen Consumption; D013565:Sympatholytics / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D013565:Sympatholytics
Justification pharmacologique de l'utilisation des inhibiteurs beta-adrénergiques dans l'angor.